Redian新闻
>
anyone still holds ITMN long?
avatar
anyone still holds ITMN long?# Stock
E*X
1
Sell on news tomorrow?
Waterfall on rejection tomorrow?
Another leg up after approval tomorrow?
1. EXECUTIVE SUMMARY
1.1 Conclusions and Recommendations
InterMune, Inc. has proposed Esbriet® (pirfenidone) capsule for “the
treatment of patients with
idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function.”
The information for the
proposed use of pirfenidone 2403 mg/d in IPF patients consists of the
efficacy and safety data
collected from Study 004 and Study 006.
Based on my co
avatar
c*x
2

I believe the 60% run on Friday has already priced in the positive panel
review. So there is no more upside left only downside. It can go back to
low teens if there is no unanimous vote tomorrow.

【在 E***X 的大作中提到】
: Sell on news tomorrow?
: Waterfall on rejection tomorrow?
: Another leg up after approval tomorrow?
: 1. EXECUTIVE SUMMARY
: 1.1 Conclusions and Recommendations
: InterMune, Inc. has proposed Esbriet® (pirfenidone) capsule for “the
: treatment of patients with
: idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function.”
: The information for the
: proposed use of pirfenidone 2403 mg/d in IPF patients consists of the

avatar
E*X
3
Agree, I estimate the upside to be another $4 possible due to short squeeze
if it is approved. If no good news, I think it will fall but should find
support around $7.5-10.
avatar
r*o
4
I have long exposure, but I'm waiting for the vol to go down, the near term
vol is 400% now, which is ridiculous...
Tomorrow if ITMN stays above $10, and vol goes down, I make money.
相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。